Loading clinical trials...
Loading clinical trials...
This study will assess efficacy and safety of intraseasonal specific short-term immunotherapy with Depiquick® Birch in patients with allergic rhinitis and or rhinoconjunctivitis with or without interm...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Novartis
NCT06778213 · Allergic Rhinoconjunctivitis
NCT06922448 · Allergic Rhinoconjunctivitis
NCT04502966 · Allergic Rhinoconjunctivitis, Grass Pollen Allergy
NCT04874714 · Allergic Rhinoconjunctivitis, Perennial Allergic Rhinitis, and more
NCT03850626 · Allergic Rhinoconjunctivitis, Allergic Asthma
Novartis Investigative Site
Aachen
Novartis Investigative Site
Aschaffenburg
Novartis Investigative Site
Augsburg
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions